companydata.dkELI LILLY DANMARK A/S
CVR: 51619811
Secondary names: GEMELLI A/S, ELI LILLY EXPORT A/S, Immunitrack A/S
Previous names: ELI LILLY AND COMPANY DENMARK ApS, ELI LILLY DENMARK A/S
The financial health of ELI LILLY DANMARK A/S shows signs of decline, particularly in profitability, with a reported loss of 9.6 million DKK in 2024 following a profit of 16.3 million DKK in 2023. Revenue decreased from 662.6 million DKK in 2023 to 598.0 million DKK in 2024, indicating a downward trend despite a previous increase to 605.6 million DKK in 2022. The company's equity has also decreased from 56.2 million DKK in 2023 to 46.6 million DKK in 2024, raising concerns about its financial stability. Overall, while ELI LILLY DANMARK A/S has a significant presence in the pharmaceutical wholesale industry, its declining margins and equity position suggest challenges ahead.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 31.1.1975
Details
- Employees
- 61 employees
- 69 FTE
- (2018)
- Capital
- 10.000.000 kr.
Contact
- Phone
- Log in to see
Purpose
Selskabets formål er at drive handel og fabrikation samt hermed beslægtet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 598 mio. | -9.6 mio. | 207.4 mio. | 46.6 mio. | 71 | |
History
Ownership
Management
Directors
Board
Production units (3)
Similar companies
Companies in the same industry and area